IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates28-06-2022
28-06-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Intimation Of Incorporation Of Wholly Owned Subsidiary
Pursuant to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that IOL Speciality Chemicals Limited has been incorporated as wholly owned subsidiary of the Company on 24th June 2022. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/ CFD/CMD/4/ 2015 dated 9th September, 2015 are attached as an Annexure A to this letter.28-06-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Intimation Of Incorporation Of Wholly Owned Subsidiary
Pursuant to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that IOL Life Sciences Limited has been incorporated as wholly owned subsidiary of the Company on 20th June 2022. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/ CFD/CMD/4/ 2015 dated 9th September, 2015 are attached as an Annexure A to this letter. This is for information and record.21-06-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Officials of the Company would be participating through virtual call in the 'Ground View Conference 2022' being organized by PhillipCapital (India) Pvt Ltd15-06-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Disclosure Of Related Party Transaction
In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions in the format specified under SEBI Circular No. SEBI/HO/CFD/CMDl/OR/P/2021/662 dated 22nd November, 2021, for the half year ended on 31st March, 2022. This is for your information & record.14-06-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Clarification With Regard To Increase In Volume
With reference to your mail and Letter reference no. : L/SURV/ONL/PV/VK/ 2022-2023 / 82 dated 13th June 2022, we wish to submit that there is no such announcement or price sensitive information, which is pending to be intimated by the Company to the Stock Exchange that have a bearing on the operation /performance of the Company. We would like to further inform and clarify that all the information furnished by the Company is in public domain and Company will keep the Stock Exchanges duly informed of all the price sensitive information(s) in compliance with SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.13-06-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Clarification sought from IOL Chemicals & Pharmaceuticals Ltd
The Exchange has sought clarification from IOL Chemicals & Pharmaceuticals Ltd on June 13, 2022, with reference to Movement in Volume.The reply is awaited.13-06-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 201510-06-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Earnings Conference Call, post declaration of audited financial results for the quarter and year ended 31st March 202207-06-2022
Earnings Call for Q4FY22 of IOL Chemicals and Pharmaceuticals
Conference Call with IOL Chemicals and Pharmaceuticals Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.01-06-2022